SMTL ID : 5e1s.1

The Crystal structure of INSR Tyrosine Kinase in complex with the Inhibitor BI 885578

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.26 Å

Oligo State

monomer

Ligands

1 x 5JA: (5R)-N-(1-{2-[4-(2-methoxyethyl)piperazin-1-yl]ethyl}-1H-pyrazol-3-yl)-5,8-dimethyl-9-phenyl-6,8-dihydro-5H-pyrazolo[3,4-h]quinazolin-2-amine(Non-covalent)

5JA.1: 19 residues within 4Å: Chain A: R.25, L.27, G.28, Q.29, G.30, V.35, A.53, K.55, V.85, E.102, L.103, M.104, A.105, H.106, G.107, D.108, N.122, M.164, D.175 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.27, A:L.27, A:V.35, A:A.53, A:V.85 Hydrogen bonds: A:M.104, A:M.104, A:N.122

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sanderson, M.P. et al., BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis. Mol.Cancer Ther. (2015)

Release Date

2015-10-14

Peptides

Insulin receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Insulin receptor